Gland Pharma Limited (BOM:543245)

India · Delayed Price · Currency is INR

1,669.00

-35.90 (-2.11%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	56.17B	56.65B	36.25B	44.01B	34.63B
Pharmaceuticals Growth	-0.85%	56.29%	-17.64%	27.08%	31.51%
Total	56.17B	56.65B	36.25B	44.01B	34.63B
Total Growth	-0.85%	56.29%	-17.64%	27.08%	31.51%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
USA	27.40B	26.88B	20.91B	23.33B	21.28B
USA Growth	1.95%	28.54%	-10.36%	9.61%	21.09%
Europe	10.23B	10.53B	1.87B	2.40B	1.51B
Europe Growth	-2.88%	462.62%	-21.97%	59.06%	29.00%
India	4.77B	5.88B	5.55B	8.80B	5.56B
India Growth	-18.95%	5.97%	-36.96%	58.17%	19.10%
Rest of World (ROW)	11.38B	11.82B	6.89B	8.48B	5.46B
Rest of World (ROW) Growth	-3.72%	71.43%	-18.73%	55.46%	135.57%
Canada	1.57B	890.27M	794.90M	829.19M	659.46M
Canada Growth	76.83%	12.00%	-4.14%	25.74%	40.57%
Australia	742.94M	626.45M	218.24M	170.87M	160.38M
Australia Growth	18.60%	187.05%	27.72%	6.54%	22.05%
New Zealand	77.23M	28.17M	10.86M	-	-
New Zealand Growth	174.16%	159.39%	-	-	-
Total	56.17B	56.65B	36.25B	44.01B	34.63B
Total Growth	-0.85%	56.29%	-17.64%	27.08%	31.51%

Source: S&P Global Market Intelligence.